International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
NCT05590715 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2026-04-27
Summary
To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication
Conditions
Sponsors & Collaborators
-
Stalicla SA
lead INDUSTRY
Principal Investigators
-
Paulo Fontoura, MD, PhD · Stalicla SA
Eligibility
- Min Age
- 12 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-13
- Primary Completion
- 2027-03-31
- Completion
- 2027-05-31
Countries
- United States
- Australia
- Spain
Study Locations
More Related Trials
-
Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children
NCT05675371 ·Status: COMPLETED
-
Understanding the Mechanisms of Autism : an MRI and Social Cognition Study
NCT06334588 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study of Microbiome in Patients With Autism Spectrum Disorder and Their Unaffected Siblings
NCT05038748 ·Status: COMPLETED
-
A Repeatability and Reproducibility Study of the EarliPoint™ Device
NCT04860986 ·Status: COMPLETED
-
Psilocybin in Adults With and Without Autism Spectrum Disorder
NCT05651126 ·Status: COMPLETED ·Phase: NA
-
Precise Objective Automated Assessment System of Autism Spectrum Disorder From an Existing Big Cohort
NCT04875481 ·Status: COMPLETED
-
ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)
NCT05889273 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder
NCT03835117 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder
NCT03664232 ·Status: COMPLETED ·Phase: PHASE2
-
A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum Disorder
NCT05067582 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Personal Identity in Adults With Autism Spectrum Disorder Without Intellectual Deficiency
NCT02747056 ·Status: COMPLETED ·Phase: NA
-
A Deep Learning Algorithm Platform to Predict Autism Diagnosis and Subtypes
NCT04873674 ·Status: RECRUITING
-
Nutritional and Dietary Treatment Study for Children/Adults With Autism
NCT02059577 ·Status: COMPLETED ·Phase: PHASE2
-
Intestinal Microbiota, Tryptophan and Autism
NCT03751930 ·Status: COMPLETED
-
Screening for Autism Spectrum Disorders Using Auditory Brainstem Responses
NCT03971578 ·Status: COMPLETED
-
TB006 for Autism Spectrum Disorder
NCT06500637 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Some Inflammatory Markers in Autism Spectrum Disorders
NCT05803005 ·Status: UNKNOWN
-
A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's Syndrome
NCT01669889 ·Status: COMPLETED
-
A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
NCT07285798 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Autism Biomarker Consortium for Clinical Trials
NCT02996669 ·Status: COMPLETED
-
A Pilot Study to Develop a Behavior-based Screening Protocol for Early Diagnosis of Autism Spectrum Disorders
NCT06339359 ·Status: RECRUITING
-
From Molecules to Cognition: Inhibitory Mechanisms in ASD and NF1
NCT03826940 ·Status: COMPLETED ·Phase: NA
-
The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study
NCT05294705 ·Status: COMPLETED
-
Transcranial Magnetic Stimulation Studies in Autism Spectrum Disorders
NCT02591446 ·Status: COMPLETED
-
Clinical and Neurophysiological Evolutions Through a Functional Rehabilitation of Social Communication in ASD
NCT02444117 ·Status: COMPLETED